FDA Advisory Panel Unanimously Recommends Expanded Indication For Boston Scientific's Heart Failure Devices Based On Landmark MADIT-CRT Trial
NATICK, Massachusetts, March 23, 2010 /PRNewswire/ -- Boston Scientific Corporation today announced that the Circulatory System Devices Panel of the U.S. Food and Drug Administration (FDA) has…